C

Creative Medical Technology Holdings
D

CELZ

2.23000
USD
-0.12
(-4.90%)
مغلق
حجم التداول
5,367
الربح لكل سهم
-1
العائد الربحي
-
P/E
-1
حجم السوق
8,243,570
أصول ذات صلة المقالات
المزيد

العنوان: Creative Medical Technology Holdings

القطاع: Healthcare
الصناعة: Biotechnology
Creative Medical Technology Holdings Inc is a commercial-stage biotechnology company focused on the advancement of regenerative therapies in the fields of immunotherapy, endocrinology, urology, neurology, and orthopedics. Its pipeline consists of AlloStem (CELZ-201-DDT); ImmCelz (CELZ-100), a personalized supercharged immune therapy platform; CELZ-201 CREATE-1, an intervention for the treatment of recent onset Type 1 Diabetes; AlloStemSpine for treatment of lower back pain; the Alova program to treat infertility as a result of premature ovarian failure; and other regenerative treatment programs and technologies like OvaStem, CaverStem, FemCelz, StemSpine, and others for the treatment of various indications related to sexual health, spine disc disease, kidney failure, liver failure, etc.